A critical misconfiguration in Amazon Web Services (AWS) CodeBuild could have allowed complete takeover of the cloud service provider's own GitHub repositories, including its AWS JavaScript SDK, ...

Amazon Web Services (AWS) has updated the pricing structure for some of its Elastic Compute Cloud (Amazon EC2) Capacity Blocks for ML offerings. Raised by approximately 15%, this move could affect ...

LAS VEGAS--(BUSINESS WIRE)-- At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. (AMZN) company, today announced three frontier agents: Kiro autonomous agent, AWS Security Agent, ...

Frontier agents represent a new class of AI agents that are autonomous, scalable, and work for hours or days without constant intervention. Kiro autonomous agent is your virtual developer that ...

LAS VEGAS--(BUSINESS WIRE)--At AWS re:Invent, Amazon Web Services, Inc. (AWS), an Amazon.com, Inc. company (NASDAQ: AMZN), today announced three frontier agents: Kiro autonomous agent, AWS Security ...

Amazon Web Services (AWS) is leaning into the growing trend toward custom models with a new service that it says will let enterprises bring more personalization and internal knowledge. The move comes ...

CrowdStrike becomes the first cybersecurity partner to deliver an enhanced version of SaaS Quick Launch in AWS Marketplace for fully integrated Falcon Next-Gen SIEM; CrowdStrike Falcon Next-Gen SIEM ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Consumers challenging drip pricing practices cite the FTC rule as persuasive authority that supports state-law claims to recover hidden fees under unfair-and-deceptive-practices statutes and the ...

Ticket reseller Vivid Seats is facing a proposed class action lawsuit claiming it lured customers with deceptively low prices before tacking on hidden fees at checkout — a practice known as “drip ...

NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the pricing of its ...